Identification and Validation of a m5C RNA Modification-Related Gene Signature for Predicting Prognosis and Immunotherapeutic Efficiency of Gastric Cancer

Table 1

Characteristics of patients in the training set and the testing set from the TCGA-GC cohort.

Characteristics	n	Training set	Testing set	value
Total cases	148	102	46
Age
≤60	65	43	22
>60	83	59	24	0.074
Metastasis
M0	139	96	43
M1	9	6	3	0.627
Node
N0	30	20	10
N1	46	31	15
N2	32	23	9
N3	40	28	12	0.002
Stage grouping
Stage I	7	4	3
Stage II	49	32	17
Stage III	77	56	21
Stage IV	15	10	5	0.310
Tumor
T1	1	1	0
T2	27	16	11
T3	80	60	20
T4	40	25	15	0.330
Treatment type
Pharmaceutical therapy	86	58	28
Radiation and pharmaceutical therapy	61	44	17
Radiation therapy	1	0	1	0.385
Gender
Female	51	35	16
Male	97	67	30	0.250

Statistical significance is shown in bold.